These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7076786)
1. A Bayesian approach to the interpretation of subgroup results in clinical trials. Donner A J Chronic Dis; 1982; 35(6):429-35. PubMed ID: 7076786 [TBL] [Abstract][Full Text] [Related]
2. Bayesian and non-Bayesian methods of inference. Small RD; Schor SS Ann Intern Med; 1983 Dec; 99(6):857-9. PubMed ID: 6360005 [No Abstract] [Full Text] [Related]
3. Bayesian statistics in oncology: a guide for the clinical investigator. Adamina M; Tomlinson G; Guller U Cancer; 2009 Dec; 115(23):5371-81. PubMed ID: 19691089 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials: is the Bayesian approach ready for prime time? Yes! Berry DA Stroke; 2005 Jul; 36(7):1621-2. PubMed ID: 15947276 [No Abstract] [Full Text] [Related]
5. Stopping rules and estimation problems in clinical trials. Hughes MD; Pocock SJ Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947 [TBL] [Abstract][Full Text] [Related]
6. An introduction to Bayes' theorem and examples of its application to a diagnostic test and a clinical trial. Thi Mai H; He S; Alexandrou E; Alfred Frost S Nurse Res; 2022 Mar; 30(1):39-43. PubMed ID: 35174675 [TBL] [Abstract][Full Text] [Related]
7. Designing for nonparametric Bayesian survival analysis using historical controls. Van Ryzin J Cancer Treat Rep; 1980; 64(2-3):503-6. PubMed ID: 7407791 [TBL] [Abstract][Full Text] [Related]
8. [Count on your beliefs. Bayes--not the P value--measures credence]. Taube A; Malmquist J Lakartidningen; 2001 Jul; 98(28-29):3208-11. PubMed ID: 11496808 [TBL] [Abstract][Full Text] [Related]
9. The exclusion of patients from a clinical trial. Donner A Stat Med; 1982; 1(3):261-5. PubMed ID: 7187098 [TBL] [Abstract][Full Text] [Related]
10. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches. Zaslavsky BG; Scott J J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117 [TBL] [Abstract][Full Text] [Related]
11. Clinical trials and statistical verdicts: probable grounds for appeal. Diamond GA; Forrester JS Ann Intern Med; 1983 Mar; 98(3):385-94. PubMed ID: 6830080 [TBL] [Abstract][Full Text] [Related]
14. A Bayesian subgroup analysis with a zero-enriched Polya Urn scheme. Sivaganesan S; Laud PW; Müller P Stat Med; 2011 Feb; 30(4):312-23. PubMed ID: 21225894 [TBL] [Abstract][Full Text] [Related]
15. A Bayesian approach to subgroup identification. Berger JO; Wang X; Shen L J Biopharm Stat; 2014; 24(1):110-29. PubMed ID: 24392981 [TBL] [Abstract][Full Text] [Related]
16. Model averaging for treatment effect estimation in subgroups. Bornkamp B; Ohlssen D; Magnusson BP; Schmidli H Pharm Stat; 2017 Mar; 16(2):133-142. PubMed ID: 27935199 [TBL] [Abstract][Full Text] [Related]
17. Empirical Bayes estimates of subgroup effects in clinical trials. Davis CE; Leffingwell DP Control Clin Trials; 1990 Feb; 11(1):37-42. PubMed ID: 2157579 [TBL] [Abstract][Full Text] [Related]
18. An introduction to the Bayesian analysis of clinical trials. Lewis RJ; Wears RL Ann Emerg Med; 1993 Aug; 22(8):1328-36. PubMed ID: 8333640 [TBL] [Abstract][Full Text] [Related]
19. Bayesian predictive approach to interim monitoring in clinical trials. Dmitrienko A; Wang MD Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570 [TBL] [Abstract][Full Text] [Related]
20. Practical Bayesian guidelines for phase IIB clinical trials. Thall PF; Simon R Biometrics; 1994 Jun; 50(2):337-49. PubMed ID: 7980801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]